Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes.

Gene therapy may be of benefit in human immunodeficiency virus type 1 (HIV-1)-infected individuals by virtue of its ability to inhibit virus replication and prevent viral gene expression. It is not known whether anti-HIV-1 gene therapy strategies based on antisense or transdominant HIV-1 mutant prot...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Vandendriessche, T, Chuah, M K, Chiang, L, Chang, H K, Ensoli, B, Morgan, R A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189138/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7769662/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.69.7.4045-4052.1995
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!